Self-Guided Multiple Instance Learning for Weakly Supervised Disease Classification and Localization in Chest Radiographs
Not on the map. Why?
Abstract (arXiv)
The lack of fine-grained annotations hinders the deployment of automated diagnosis systems, which require human-interpretable justification for their decision process. In this paper, we address the problem of weakly supervised identification and localization of abnormalities in chest radiographs. To that end, we introduce a novel loss function for training convolutional neural networks increasing the localization confidence and assisting the overall disease identification. The loss leverages both image- and patch-level predictions to generate auxiliary supervision. Rather than forming strictly binary from the predictions as done in previous loss formulations, we create targets in a more customized manner, which allows the loss to account for possible misclassification. We show that the supervision provided within the proposed learning scheme leads to better performance and more precise predictions on prevalent datasets for multiple-instance learning as well as on the NIH~ChestX-Ray14 benchmark for disease recognition than previously used losses.
Key facts. Cited by 3 papers in the map (data through 7 Oct 2026). First posted on arXiv 30 Sep 2020.
Builds on
No reference list yet.
Built on by
Citing papers per year: 2021: 1; 2022: 1; 2023: 1.
3 papers.
- 2021Reference-guided Pseudo-Label Generation for Medical Semantic Segmentationcited by 33
- 2022Breaking with Fixed Set Pathology Recognition through Report-Guided Contrastive Trainingcited by 26
- 2023Accurate Fine-Grained Segmentation of Human Anatomy in Radiographs via Volumetric Pseudo-Labelingcited by 24
- 2023Accurate Fine-Grained Segmentation of Human Anatomy in Radiographs via Volumetric Pseudo-Labeling6 Jun 2023
- 2022Breaking with Fixed Set Pathology Recognition through Report-Guided Contrastive Training14 May 2022
- 2021Reference-guided Pseudo-Label Generation for Medical Semantic Segmentation1 Dec 2021